The Synergistic Effect of Sorafenib and Dasatinib Combined Treatment in Human Hepatocellular Carcinoma Cells

The Synergistic Effect of Sorafenib and Dasatinib Combined Treatment in Human Hepatocellular Carcinoma Cells

碩士 === 東海大學 === 生命科學系 === 107

Bibliographic Details
Main Authors:	SHIH, JING-HAO, 施景皓
Other Authors:	CHAO, WEI-TING
Format:	Others
Language:	en_US
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/handle/3y8s79

Similar Items

Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
by: Yafei Zhang, et al.
Published: (2012-09-01)

Radiosensitization effect of Sorafenib in hepatocellular carcinoma treatment
by: John Chun-Hao Chen, et al.
Published: (2018)

Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01)

Sorafenib for the treatment of unresectable hepatocellular carcinoma
by: Junji Furuse
Published: (2008-11-01)

Sorafenib for the treatment of advanced hepatocellular carcinoma
by: M Connock, et al.
Published: (2010-05-01)

Treatment of Large Hepatocellular Carcinoma using Transarterial Chemoembolisation Combined with Sorafenib
by: SD Madhu, et al.
Published: (2021-01-01)

OSU-2S/sorafenib synergistic antitumor combination against hepatocellular carcinoma: The role of PKCδ/p53
by: Hany A Omar, et al.
Published: (2016-11-01)

Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
by: Khaldoun Almhanna, et al.
Published: (2009-11-01)

Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
by: Jeong-Ju Yoo, et al.
Published: (2019-03-01)

Synergistic Effect of Sorafenib Combined with Radiation or Vorinostat on Human Hepatocellular Carcinoma is via Inhibition of ERK/NF-κB Signaling Pathway
by: Fei-Ting Hsu, et al.
Published: (2014)

Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells
by: Chiu CM, et al.
Published: (2018-03-01)

Research advances in transarterial chemoembolization combined with sorafenib in treatment of advanced hepatocellular carcinoma
by: WU Lei, et al.
Published: (2018-04-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01)

Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells
by: Wu M, et al.
Published: (2018-05-01)

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
by: Zhang YF, et al.
Published: (2016-07-01)

Sorafenib combined with thanscatheter artierial chemoembolzation in treatment of advanced hepatocellular carcinoma: Meta analysis
by: YANG Jun
Published: (2013-10-01)

Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
by: Ha Ra Gu, et al.
Published: (2015-03-01)

Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.
by: Aaron T Wild, et al.
Published: (2013-01-01)

A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma
by: Kai Zhang, et al.
Published: (2018-12-01)

Evaluation of Sorafenib therapy in hepatocellular carcinoma
by: Ana Margarida da Cruz Alves
Published: (2019)

Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.
by: Sangheun Lee, et al.
Published: (2013-01-01)

Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib
by: Duan W, et al.
Published: (2018-07-01)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020-08-01)

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.
by: Hitomi Takada, et al.
Published: (2018-01-01)

Treatment options after sorafenib failure in patients with hepatocellular carcinoma
by: Imane El Dika, et al.
Published: (2017-12-01)

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial)
by: Ioana Riaño, et al.
Published: (2020-07-01)

Study the anti-metastatic molecular mechanism of a combination of metformin and sorafenib in human hepatocellular carcinoma
by: Shu-Ching Hsieh, et al.
Published: (2015)

Synergistic inhibitory effect of hyperbaric oxygen combined with sorafenib on hepatoma cells.
by: Hai-Shan Peng, et al.
Published: (2014-01-01)

The study of mechanism underlying sorafenib efficacy in hepatocellular carcinoma cells
by: Po-Chiao Huang, et al.
Published: (2018)

Downregulation of Dicer Confers Sorafenib Resistance in Hepatocellular Carcinoma Cells
by: Chi-Feng Tseng, et al.
Published: (2013)

Nano lipidic carriers for codelivery of sorafenib and ganoderic acid for enhanced synergistic antitumor efficacy against hepatocellular carcinoma
by: Bin Wang, et al.
Published: (2021-08-01)

CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
by: Young Chang, et al.
Published: (2020-10-01)

Cost effectiveness of sorafenib for advanced hepatocellular carcinoma
by: Jung-Chen Ho, et al.
Published: (2017)

Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
by: Yi-Ling Ko, et al.
Published: (2020-04-01)

Cerebrovascular Accidents Associated with Sorafenib in Hepatocellular Carcinoma
by: Muhammad W. Saif, et al.
Published: (2011-01-01)

Sorafenib, a systemic therapy for hepatocellular carcinoma
by: Nahum Méndez-Sánchez;, et al.
Published: (2008-01-01)

Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma
by: Gu, D.-L, et al.
Published: (2022)

Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
by: Faezeh Hosseinzadeh, et al.
Published: (2018-09-01)

Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells
by: Yeonghoon Son, et al.
Published: (2021-05-01)

Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment
by: Seok Bae Kim
Published: (2021-07-01)